- Home
- CDNA vs DEC Comparison
CDNA vs DEC Comparison
Compare CDNA & DEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- DEC
- Stock Information
- Founded
- CDNA 1998
- DEC 2001
- Country
- CDNA United States
- DEC United States
- Employees
- CDNA N/A
- DEC N/A
- Industry
- CDNA Medical Specialities
- DEC
- Sector
- CDNA Health Care
- DEC
- Exchange
- CDNA Nasdaq
- DEC Nasdaq
- Market Cap
- CDNA 844.7M
- DEC 696.2M
- IPO Year
- CDNA 2014
- DEC N/A
- Fundamental
- Price
- CDNA $16.99
- DEC $14.00
- Analyst Decision
- CDNA Buy
- DEC Strong Buy
- Analyst Count
- CDNA 6
- DEC 4
- Target Price
- CDNA $30.33
- DEC $20.75
- AVG Volume (30 Days)
- CDNA 1.4M
- DEC 373.1K
- Earning Date
- CDNA 04-30-2025
- DEC 01-01-0001
- Dividend Yield
- CDNA N/A
- DEC 8.30%
- EPS Growth
- CDNA N/A
- DEC N/A
- EPS
- CDNA 1.07
- DEC N/A
- Revenue
- CDNA $346,421,000.00
- DEC $758,798,000.00
- Revenue This Year
- CDNA $13.38
- DEC $46.42
- Revenue Next Year
- CDNA $15.33
- DEC $9.54
- P/E Ratio
- CDNA $15.81
- DEC N/A
- Revenue Growth
- CDNA 25.92
- DEC N/A
- 52 Week Low
- CDNA $12.90
- DEC $10.08
- 52 Week High
- CDNA $34.84
- DEC $17.70
- Technical
- Relative Strength Index (RSI)
- CDNA 49.78
- DEC 58.98
- Support Level
- CDNA $16.57
- DEC $13.63
- Resistance Level
- CDNA $18.02
- DEC $14.70
- Average True Range (ATR)
- CDNA 0.77
- DEC 0.40
- MACD
- CDNA 0.14
- DEC 0.02
- Stochastic Oscillator
- CDNA 59.45
- DEC 52.31
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
About DEC Diversified Energy Company plc
Diversified Energy Co PLC is an independent energy company focused on natural gas and liquids production, transportation, marketing, and well retirement, predominantly located within the Appalachian and Central regions of the United States. The company acquires and manages gas and oil properties and certain associated midstream assets. Its operations are located throughout the neighboring states of Tennessee, Kentucky, Virginia, West Virginia, Ohio, Pennsylvania, Oklahoma, Texas, and Louisiana. The company has one reportable segment that produces and transports natural gas, natural gas liquids (NGLs), and oil in the United States.